Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney Davis

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Social Science & Medicine (1982)|April 9, 2011
The socio-political roots of pharmaceutical uncertainty in the evaluation of 'innovative' diabetes drugs in the European Union and the USCourtney Davis, John Abraham
Health Research Policy and Systems|November 16, 2018
Regulatory scientists' work has important ramifications for public health and should be open to public scrutinyShai Mulinari, Courtney Davis
BMJ (Clinical Research Ed.)|February 8, 2013
Is there a cure for corporate crime in the drug industry?Courtney Davis, John Abraham
Social Science & Medicine (1982)|May 4, 2020
International and temporal comparative analysis of UK and US drug safety regulation in changing political contextsJohn Abraham, Courtney Davis
Social Science & Medicine (1982)|December 7, 2021
Corrigendum to "International and temporal comparative analysis of UK and US drug safety regulation in changing political contexts" [Soc. Sci. Med. 255 (2020) 113005]John Abraham, Courtney Davis
Lancet (London, England)|October 15, 2015
EXAMINE: targeting risk and treatment in diabetesDaniel M Riche, Courtney Davis
The Journal of Pediatrics|April 26, 2021
Higher-calorie vs lower-calorie refeeding in patients with anorexia improves time to medical stability without compromising safetyCourtney Davis, Chu Shan Elaine Chew
BMJ (Clinical Research Ed.)|December 1, 2021
Putting patients first in medicines regulation?Huseyin Naci, Robin Forrest, Courtney Davis
Plos Medicine|January 27, 2016
Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012Andreas Vilhelmsson, Courtney Davis, Shai Mulinari
The Milbank Quarterly|October 6, 2020
Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United StatesMaximilian Salcher-Konrad, Huseyin Naci, Courtney Davis
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Social Science & Medicine (1982)|April 9, 2011
The socio-political roots of pharmaceutical uncertainty in the evaluation of 'innovative' diabetes drugs in the European Union and the USCourtney Davis, John Abraham
Health Research Policy and Systems|November 16, 2018
Regulatory scientists' work has important ramifications for public health and should be open to public scrutinyShai Mulinari, Courtney Davis
BMJ (Clinical Research Ed.)|February 8, 2013
Is there a cure for corporate crime in the drug industry?Courtney Davis, John Abraham
Social Science & Medicine (1982)|May 4, 2020
International and temporal comparative analysis of UK and US drug safety regulation in changing political contextsJohn Abraham, Courtney Davis
Social Science & Medicine (1982)|December 7, 2021
Corrigendum to "International and temporal comparative analysis of UK and US drug safety regulation in changing political contexts" [Soc. Sci. Med. 255 (2020) 113005]John Abraham, Courtney Davis
Lancet (London, England)|October 15, 2015
EXAMINE: targeting risk and treatment in diabetesDaniel M Riche, Courtney Davis
The Journal of Pediatrics|April 26, 2021
Higher-calorie vs lower-calorie refeeding in patients with anorexia improves time to medical stability without compromising safetyCourtney Davis, Chu Shan Elaine Chew
BMJ (Clinical Research Ed.)|December 1, 2021
Putting patients first in medicines regulation?Huseyin Naci, Robin Forrest, Courtney Davis
Plos Medicine|January 27, 2016
Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012Andreas Vilhelmsson, Courtney Davis, Shai Mulinari
The Milbank Quarterly|October 6, 2020
Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United StatesMaximilian Salcher-Konrad, Huseyin Naci, Courtney Davis
Pageof 7